Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001585364-24-000130
Filing Date
2024-10-08
Accepted
2024-10-08 15:53:47
Documents
3
Period of Report
2024-10-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1728417220.html 3  
1 FORM 3 wk-form3_1728417220.xml 3 2268
2 EX-24 poa-charlesatkinson.htm EX-24 3153
3 GRAPHIC poa-charlesatkinson001.jpg GRAPHIC 206299
  Complete submission text file 0001585364-24-000130.txt   291234
Mailing Address 515 EASTERN AVENUE ALLEGAN MI 49010
Business Address THE SHARP BUILDING HOGAN PLACE DUBLIN 2 L2 D02 TY74 269-673-8451
PERRIGO Co plc (Issuer) CIK: 0001585364 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O PERRIGO COMPANY PLC 430 MONROE AVE NW GRAND RAPIDS MI 49503
Business Address
Atkinson Charles (Reporting) CIK: 0002039166 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36353 | Film No.: 241360278